Knowledge Hub - Public Pharma For Europe

Access materials related to Public Pharma

Making Access to Quality Healthcare a Top Priority for the EU

Against the normalization of limited access to CAR-T cell therapies

Opinion article

If Not Now, Then When? Reimagining Global Health Equity

Opinion article

Fearing Trump cuts, California Democrat proposes creating state’s own NIH

Leven van Erik (55) uit Oosterhesselen gered door experimenteel medicijn UMCG. ‘Kritiek farmalobby tenenkrommend’

Para confrontar a Big Pharma, Farmacêuticas Públicas

Shortage of antiseizure medication in Germany: How big is the problem?

What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing

Prix des médicaments : “Le modèle d’affaire de l’industrie pharmaceutique sert à maximiser ses profits”

Public Pharma: What It Is and Why It’s Important?

Keep In Touch